• CBD Mitigates Orofacial Pain and Emotional Deficits via Mult

  2026-05-28

  This study reveals that cannabidiol (CBD) significantly alleviates both sensory and affective dimensions of orofacial inflammatory pain in mice by modulating endocannabinoid and serotonergic pathways. These findings advance our understanding of multidimensional pain regulation and highlight the translational potential of CBD-based interventions for complex pain syndromes.

• Robust Reporter Assays with EZ Cap™ mCherry mRNA (5mCTP, ψUT

  2026-05-27

  This article examines real-world laboratory challenges in cell viability and fluorescent reporter assays, highlighting how EZ Cap™ mCherry mRNA (5mCTP, ψUTP) (SKU R1017) optimizes reproducibility and signal fidelity. By integrating scenario-driven Q&A and referencing both product and literature data, we offer actionable guidance for researchers seeking reliable, immune-evasive red fluorescent protein mRNA solutions.

• Ceftolozane/Tazobactam: Advancements in Treating Resistant I

  2026-05-27

  The referenced study reviews ceftolozane/tazobactam as a novel β-lactam/β-lactamase inhibitor combination, highlighting its enhanced efficacy against multidrug-resistant gram-negative pathogens, notably Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae. Population PK/PD modeling and clinical trial results establish new dosing benchmarks, informing translational and experimental research workflows.

• Chloroquine (SKU BA1002): Practical Solutions for Cell-Based

  2026-05-26

  This article provides scenario-driven, evidence-based guidance for researchers using Chloroquine (SKU BA1002) in cell viability, cytotoxicity, and mechanistic assays. We address experimental challenges, protocol optimization, and vendor selection, highlighting the reproducibility and scientific rigor that APExBIO’s product brings to advanced biomedical workflows.

• Promethazine HCl: Advancing Host-Directed Immunology Researc

  2026-05-26

  This thought-leadership article explores how Promethazine HCl, a phenothiazine derivative and histamine H1 receptor antagonist, is redefining immunological and translational research. By integrating recent mechanistic findings—especially its role in macrophage activation via ROS and autophagy induction—this piece offers a strategic roadmap for researchers seeking to leverage host-directed therapeutics in the era of antimicrobial resistance. The discussion contextualizes Promethazine HCl within the competitive reagent landscape, highlights its translational potential, and provides actionable protocol parameters, while differentiating APExBIO’s product for advanced experimental design.

• SB 431542: ALK5 Inhibitor Protocols for TGF-β Pathway Contro

  2026-05-25

  SB 431542, a highly selective ALK5 inhibitor, empowers researchers to dissect TGF-β signaling and drive functional advances in regenerative medicine, cancer biology, and immunology. This article breaks down experimental workflows, troubleshooting strategies, and real-world protocol enhancements inspired by cutting-edge reference studies.

• Tunicamycin: Applied Protocols for N-Glycosylation Inhibitio

  2026-05-25

  Unlock the power of Tunicamycin as a precise N-glycosylation inhibitor for dissecting ER stress and inflammation suppression. This guide delivers protocol parameters, troubleshooting strategies, and the latest evidence on endothelial inflammation, ensuring reproducibility and workflow efficiency in cell and tissue models.

• TAK-242 (Resatorvid): Unveiling Microglial Modulation in TLR

  2026-05-24

  Explore how TAK-242 (Resatorvid), a selective TLR4 inhibitor, uniquely modulates microglial polarization and inflammatory signaling in neuroinflammation research. This article delivers an advanced, evidence-focused analysis distinct from existing resources.

• TAK-242 (Resatorvid): Redefining TLR4 Modulation in Translat

  2026-05-23

  This thought-leadership article explores the mechanistic underpinnings and translational applications of TAK-242 (Resatorvid), a selective TLR4 inhibitor. It contextualizes TLR4 signaling in inflammation and osteogenesis, draws on the latest cross-tissue discoveries, and offers strategic guidance for researchers advancing from bench to bedside.

• Tofacitinib Reverses GM-CSF-Induced Dysfunction in RA Macrop

  2026-05-22

  The referenced study demonstrates that tofacitinib (CP-690550) uniquely reverses both inflammatory and metabolic dysregulation in GM-CSF-reprogrammed macrophages from rheumatoid arthritis (RA) patients. By targeting STAT5 signaling and normalizing mitochondrial function, tofacitinib outperforms anti-TNF, anti-IL6R, and metabolic-targeted therapies, offering new mechanistic insights for immune modulation research.

• 3D Mapping of Cardiac Organoids: Shell MEAs and E-4031 Insig

  2026-05-22

  This article reviews a recent advance in 3D electrophysiological mapping using shell microelectrode arrays to interrogate cardiac organoids. The study demonstrates high-content, spatiotemporal analysis of arrhythmogenic mechanisms and pharmacological responses, setting a new standard for disease modeling and QT interval risk assessment.

• TQB3720 Induces Ferroptosis in Prostate Cancer via AR/GPX4 A

  2026-05-21

  This study reports that TQB3720, a second-generation androgen receptor antagonist, suppresses prostate cancer growth by promoting ferroptosis through inhibition of the AR/GPX4 pathway. The findings provide mechanistic insight and a preclinical rationale for targeting ferroptosis in androgen receptor-driven prostate cancers.

• NOTCH3 R545C Mutation Drives Vascular-Neuronal Dysfunction i

  2026-05-21

  This study establishes a CRISPR/Cas9 mouse model with the NOTCH3 R545C mutation, revealing direct links between vascular pathology, neuroinflammation, and cognitive deficits in CADASIL. The work provides mechanistic insight into disease progression and offers a preclinical platform for exploring targeted interventions.

• p-Cresyl Sulfate in Endothelial Dysfunction & Calcification

  2026-05-20

  p-Cresyl sulfate (p-tolyl hydrogen sulfate) is a pivotal tool for modeling cardiovascular risk and endothelial dysfunction in chronic kidney disease research. This guide details actionable workflows, troubleshooting strategies, and the latest mechanistic insights from landmark studies, positioning APExBIO’s reagent as an indispensable asset in vascular complication studies.

• Applied Research with Methylprednisolone Sodium Succinate: P

  2026-05-20

  Methylprednisolone Sodium Succinate, a synthetic corticosteroid, sets the benchmark for precision in inflammation and immunology research. This article reveals advanced experimental workflows, actionable troubleshooting strategies, and unique comparative advantages, all grounded in peer-reviewed evidence and high-purity APExBIO sourcing.

453 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page